• Headlines

    The Corporate Social Justice Imperative

    Historically, most businesses have attempted to stay on the sidelines of controversial issues to avoid alienating customers and limit internal discord. But the COVID-19 pandemic (which has disproportionately affected people of color) and rising racial tensions have increased awareness of systemic racism in the U.S. In this Kenan Insight, we explore how business leaders are increasingly taking a stance on diversity and inclusion issues through both internally and externally focused actions and policies.

    LEARN MORE WATCH VIDEO

Up Next

October 29, 2020

Virtual Event: Dean’s Speaker Series — Harvey Gantt

LEARN MORE
 

Recent News & Media

The Seven “What Matters” In a System Not Designed for Us

September 30, 2020

For African Americans and individuals from other historically underrepresented groups, work cultures can be difficult to navigate. In a new white paper, The Seven "What Matters" In a System Not Designed for Us, Urban Investment Strategies Center Director Jim Johnson draws upon his 40 years of experience in academia to offer strategies for individuals in these groups to thrive within work cultures that do not fully embrace and may even be antagonistic to diversity and inclusion. More


Urban Investment Strategies Center

NCGrowth’s Collaboration-based Work Profiled by UNC System

September 10, 2020

As North Carolina's entrepreneurs, industries and communities move forward amidst COVID-19, Kenan Institute affiliated center NCGrowth is helping to make sure they have the tools to succeed when business can fully re-open again. More


NCGrowth

Little Named to North Carolina Black Entrepreneurship Council

August 27, 2020

Mark Little, executive director of CREATE, a Kenan Institute-affiliated center, has been named to the inaugural North Carolina Black Entrepreneurship Council (NC BEC).  The council was founded by NC IDEA, a private foundation committed to supporting entrepreneurial ambition and economic empowerment in North Carolina. More

Latest Research

The Public Can Trust the FDA’s Vaccine Review Process

October 16, 2020

With the upcoming November election and calls by President Trump for 1 or more vaccines for coronavirus disease 2019 (COVID-19) to be ready before the end of the year, if not by the election, many have started to wonder whether the US Food and Drug Administration (FDA) can withstand this type of political pressure. More